Daniel Ford has spent the past four years working for UCB and his current position is research chemist. He talks to James Berressem about his typical day
UCB is a biopharmaceutical organisation with R&D and manufacturing sites around the globe. The company develops treatments for severe diseases such as cancer, epilepsy, rheumatoid arthritis and Parkinson's disease. Daniel is one of 20 chemists working on an R&D project to make new small molecule drugs that inhibit enzymes (called kinases) which cancer cells need to grow.
Thanks for using Education in Chemistry. You can view one Education in Chemistry article per month as a visitor.
Registration is open to all teachers and technicians at secondary schools, colleges and teacher training institutions in the UK and Ireland.
Get all this, plus much more:
Already a Teach Chemistry member? Sign in now.
Not eligible for Teach Chemistry? Sign up for a personal account instead, or you can also access all our resources with Royal Society of Chemistry membership.